Back
Catalyst Pharmaceuticals Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
CPRX
Catalyst Pharmaceuticals
Last Price:
21.31
Seasonality Move:
4.48%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- The current trend is moderately bearish and CPRX is experiencing slight buying pressure.
Catalyst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.58 | Sell |
| 20-day SMA: | 22 | Sell |
| 50-day SMA: | 21.09 | Buy |
| 200-day SMA: | 17.53 | Buy |
| 8-day EMA: | 21.5 | Sell |
| 20-day EMA: | 21.69 | Sell |
| 50-day EMA: | 21.05 | Buy |
| 200-day EMA: | 18.22 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 45.27 | Sell |
| Chaikin Money Flow: | 380001 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.02 - 22.7) | Sell |
| Bollinger Bands (100): | (17.53 - 21.69) | Buy |
Catalyst Pharmaceuticals Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 21.12 while CPRX 8-day simple moving average is 21.58, which is a Sell signal.
- The stock price of CPRX is 21.12 while Catalyst Pharmaceuticals 20-day SMA is 22.00, which makes it a Sell.
- Catalyst Pharmaceuticals 50-day simple moving average is 21.09 while CPRX share price is 21.12, making it a Buy technically.
- CPRX stock price is 21.12 and Catalyst Pharmaceuticals 200-day simple moving average is 17.53, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Sell
46
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a Sell
The current Catalyst Pharmaceuticals [CPRX] share price is $21.12. The Score for CPRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
2.52B
Price in USD:
21.12
Share Volume:
807.5K
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
24.27
52-Week Low:
13.00
Sell
46
Catalyst Pharmaceuticals (CPRX)
is a Sell
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?
The Catalyst Pharmaceuticals stock price is 21.12 USD today. -
Will CPRX stock go up or go down?
Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Catalyst Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 21.12 while CPRX 8-day exponential moving average is 21.50, which is a Sell signal.
- The stock price of CPRX is 21.12 while Catalyst Pharmaceuticals 20-day EMA is 21.69, which makes it a Sell.
- Catalyst Pharmaceuticals 50-day exponential moving average is 21.05 while CPRX share price is 21.12, making it a Buy technically.
- CPRX stock price is 21.12 and Catalyst Pharmaceuticals 200-day simple moving average is 18.22, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
- CPRX Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting Catalyst Pharmaceuticals is a Buy
- Catalyst Pharmaceuticals Relative Strength Index (RSI) is 45.27, which suggest Catalyst Pharmaceuticals is oversold
- The Bollinger Bands (25) for Catalyst Pharmaceuticals is (21.02 - 22.7), which suggest Catalyst Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Catalyst Pharmaceuticals is (17.53 - 21.69), which suggest Catalyst Pharmaceuticals is a Buy
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.